ippon Medical School- Tohoku University Graduate School Intervention with Pitavastatin: Study for hypercholesterolemia with type 2 diabetes mellitus. - Nippon medical school, Tohoku university, Plaque Prevention study (NTPP study)

Dyslipidemia with diabetes study group0 个研究点目标入组 100 人开始时间: 2006年3月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)Uncontrolled diabetes mellitus (HbA1c >/= 8.0%). (2)Known hypersensitivity or history of clinically significant adverse reactions to any component of drugs. (3)Have serious hypertension (systolic blood pressure >/= 180 mmHg, or diastolic blood pressure >/= 110 mmHg) (4)History of stroke, myocardial infarction (observed within the immediate 3 months prior to screening) or heart failure. (5)Patients with serious renal disfunction or serum creatinine more than 1.5 mg/dL. (6)Patients who are relevant to contraindications listed in statin labellings. * Patients with serious liver dysfunction or biliary obstruction. * Patients who are being treated with cyclosporine. * Pregnant, possibly pregnant, or lactating. * Patients, taking fibrates, with laboratory test abnormalities in renal function.

发起方

Dyslipidemia with diabetes study group